ISSN: 2161-038X
Reproductive System & Sexual Disorders: Current Research
Like us on:
Make the best use of Scientific Research and information from our 700+ peer reviewed, Open Access Journals that operates with the help of 50,000+ Editorial Board Members and esteemed reviewers and 1000+ Scientific associations in Medical, Clinical, Pharmaceutical, Engineering, Technology and Management Fields.
Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on
Medical, Pharma, Engineering, Science, Technology and Business

DSM-5 Changes in Diagnostic Criteria of Sexual Dysfunctions

Waguih William IsHak1* and Gabriel Tobia2
1Department Psychiatry and Behavioral Sciences, Cedars-Sinai Medical Center, and Clinical Professor of Psychiatry at the David Geffen School of Medicine at UCLA, Los Angeles, California, USA
2Department of Psychiatry and Behavioral Sciences, Cedars-Sinai Medical Center, Los Angeles, California, USA
Corresponding Author : Waguih William IsHak, MD
FAPA is Vice Chairman for Education and Research
Department Psychiatry and Behavioral Sciences, Cedars-Sinai Medical Center
and Clinical Professor of Psychiatry at the David Geffen School of Medicine at UCLA
Los Angeles, California, USA
Tel: 310-423-3515
Fax: 310-423-3947
Received July 16, 2013; Accepted July 27, 2013; Published August 02, 2013
Citation: IsHak WW, Tobia G (2013) DSM-5 Changes in Diagnostic Criteria of Sexual Dysfunctions. Reprod Sys Sexual Disorders 2:122. doi:10.4172/2161-038X.1000122
Copyright: © 2013 IsHak WW, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Related article at
DownloadPubmed DownloadScholar Google

Visit for more related articles at Reproductive System & Sexual Disorders: Current Research

DSM-5; Sexual dysfunctions; Diagnosis; Nosology; Diagnostic criteria
The Diagnostic and Statistical Manual of Mental Disorders (DSM) criteria proved to be in a constant of evolution [1]. The first edition of the DSM, in 1952, catalogued 60 categories of abnormal behavior. By 1994, the fourth edition (DSM-IV) listed 297 separate disorders and over 400 specific psychiatric diagnoses [2]. As with other disorders, DSM criteria for sexual dysfunctions reflect the prevailing psychiatric thinking of the time of publication; they have thus evolved throughout the years, reflecting advancements in the understanding of sexual disorders. For instance, in the first edition of the DSM, in 1952, impotence” and “frigidity were listed under “psychophysiological autonomic and visceral disorders” [3]. Likewise, diagnostic categories of female sexual interest as described in the DSM IV 1994 [4] were based on the model of human sexual response proposed by Masters and Johnson [5], and further developed by Kaplan [6]. However, recent research has put into question the validity of that model; both the strict distinction between different phases of arousal and the linear model of sexual response were found to inadequately explain sexual behavior, particularly in women [7-9]. This has in turn led to several proposed changes in sexual dysfunction diagnostic criteria [1,10].
The DSM-5, published in May of 2013, seeks to incorporate some of aforementioned findings [11]. Changes were made in the sexual dysfunctions chapter in an attempt to correct, expand and clarify the different diagnoses and their respective criteria. Although many of the changes are subtle, some are noteworthy: gender-specific sexual dysfunctions were added, and female disorders of desire and arousal were amalgamated into a single diagnosis called “female sexual interest/arousal disorder”. Many of the diagnostic criteria were updated for increased precision: for instance, almost all DSM-5 sexual dysfunction diagnoses now require a minimum duration of 6 months as well as a frequency of 75%-100% [11].
The purpose of this article is to present and explain the changes that were introduced to the nomenclature and diagnostic criteria of sexual dysfunctions in the DSM-5.
Revised Classification
The classification of sexual dysfunctions was simplified. There are now only three female dysfunctions and four male dysfunctions, as opposed to five and six, respectively, in the DSM-IV. Female hypoactive desire dysfunction and female arousal dysfunction were merged into a single syndrome called sexual interest/arousal disorder. Similarly, the formerly separate dyspareunia and vaginismus are now called genitopelvic pain/penetration disorder. Female orgasmic disorder remains in place.
As for males, male hypoactive sexual desire disorder now has a separate entry. Male orgasmic disorder was changed to delayed ejaculation, the “male” adjective was dropped from erectile disorder, and premature ejaculation remains unchanged. Male dyspareunia or male sexual pain does not appear in the sexual dysfunctions chapter of the DSM-5.
Additionally, sexual aversion disorder and sexual dysfunction due to a general medical condition are absent from the new edition. The Not Otherwise Specified (NOS) category was scrapped from the sexual dysfunctions chapter as well as elsewhere in the DSM-5. Finally, substance- or medication-induced sexual dysfunction remains unchanged. The DSM-IV and DSM-5 classifications are compared in Table 1.
Revised Diagnostic Criteria Applicable to All Diagnoses
Unlike its predecessor, the DSM-5 includes the requirement of experiencing the disorder 75%-100% of the time to make any diagnosis of sexual disorder, with the notable exception of substanceor medication-induced disorders. Moreover, there is now a required minimum duration of approximately 6 months. Finally, in order to make a diagnosis, the disorder must be deemed to have caused significant distress (the DSM-IV requirement of “interpersonal difficulty” was removed).
One new exclusion criterion was added: the disorder should not be better explained by a “nonsexual mental disorder, a consequence of severe relationship distress (e.g., partner violence) or other significant stressors”. In addition to the existing specifiers of lifelong versus acquired disorder and generalized versus situational, a new severity scale was added: the disorder can be described as mild, moderate or severe. The subtypes indicating etiological factors (due to psychological or combined factors) were dropped.
A new group of criteria called “associated features” was also introduced. It is subdivided into five categories: 1) partner factors (e.g., partner sexual problem; partner health status); 2) relationship factors (e.g., poor communication, discrepancies in desire for sexual activity); 3) individual vulnerability factors (e.g., poor body image; history of sexual or emotional abuse), psychiatric comorbidity (e.g., depression; anxiety), or stressors (e.g., job loss; bereavement); 4) cultural or religious factors (e.g., inhibitions related to prohibitions against sexual activity or pleasure; attitudes toward sexuality); and finally 5) medical factors relevant to prognosis, course, or treatment.
Revised Diagnostic Criteria of Individual Dysfunctions
Diagnosis-specific criteria- or criteria “A” -were in most cases amended or expanded. In addition to the abovementioned duration and frequency requirements, the most important innovation is the introduction of criteria checklists, which already existed elsewhere in the DSM. A patient now needs fulfill a certain number of “A” criteriae. g. one out of three-in order to qualify for the diagnosis.
The criteria of the newly-introduced female disorder of sexual interest/arousal are based on those of hypoactive desire disorder. In addition to absent or decreased sexual interest, and erotic thoughts or fantasies, there are four new criteria taking into account absent or decreased activity in four additional aspects of sex life: initiation of sexual activity or responsiveness to a partner’s attempts to initiate it, excitement and pleasure, response to sexual cues, and sensations during sexual activity, whether genital or non-genital. Three out of six criteria are required for diagnosis.
As for the diagnosis of female orgasmic disorder, one or both of the following should be present 75%-100% of the time: absence, infrequency or delay of orgasm, and/or reduced intensity of said orgasm. Regarding the new genito-pelvic pain/penetration disorder, one of the following should occur persistently or recurrently to establish a diagnosis: difficulty in vaginal penetration, marked vulvovaginal or pelvic pain during penetration or attempt at penetration, fear or anxiety about pain in anticipation of, during, or after penetration, and tightening or tensing of pelvic floor muscles during attempted penetration.
Changes to criteria for male sexual dysfunctions are more limited in scope. The requirements for male hypoactive desire disorder are exactly the same as those for undifferentiated hypoactive desire disorder in the DSM-IV. Likewise, the criteria for erectile disorder are similar to the ones in the previous edition, with the notable addition of the 75%-100% requirement as well as the symptom of decreased erectile rigidity. The entry for delayed ejaculation-formerly male orgasmic disorder-remains essentially the same, as does that for premature ejaculation, except for an added time constraint: ejaculation must occur within approximately one minute following vaginal penetration. It should be noted that while the diagnosis of premature ejaculation diagnosis is applicable in the context of nonvaginal intercourse, there is no specific duration requirement in that case.
Finally, the diagnosis of sexual dysfunction due to a general medical is absent from the DSM-5, and the criteria for substance/medicationinduced sexual dysfunction are unchanged and include neither the 75%-100% nor the 6 months requirements.
The DSM-5 seeks to remedy some of the inconsistencies of the previous edition. Arguably, one of the major changes that the DSM- 5 introduces to the classification of sexual dysfunctions is the merger of sexual disorders of desire and arousal in females. Researchers who advocated this amalgamation [12] based their recommendations on a large body of research suggesting that the separation may have been artificial. In addition to the increased rejection of a linear model of sexual arousal [8,9], a high comorbidity of disorders of desire and arousal was demonstrated in both men and women [13,14]. However, the response to this alteration was not unanimously positive. Sarin et al. disputed the aforementioned claims and argued that the new criteria excluded an excessively large number of low desire and arousal patients [15]. Clayton et al. further argued that the combination of the two diagnoses was counterproductive because patients with hypoactive sexual disorder often presented with incomplete loss of receptivity and were therefore likely to be excluded using the new criteria [16]. Moreover, they contended that most women with sexual arousal disorder met none of the proposed “A” criteria for female sexual interest/arousal disorder and would also be left out [17].
Another important change was the fusion of the diagnoses of dyspareunia and vaginismus into a single entry named genito-pelvic pain/penetration disorder. This decision was based on the conclusion that the two disorders could not be reliably differentiated, for two main reasons. Firstly, the diagnostic formulation of vaginismus as “vaginal muscle spasm” was not supported by empirical evidence [18]. Secondly, fear of pain or fear of penetration is commonplace in clinical descriptions of vaginismus [18]. Kaplan even describes it as «phobic avoidance» [6]. Carvalho et al., after testing five alternative models of female sexual function, concluded that the diagnoses vaginismus and dyspareunia overlapped to a great degree [19]. One consequence of the collapse of the two diagnoses is male dyspareunia which, because it was deemed exceedingly rare, was scrapped completely from the nomenclature [20].
The diagnosis of sexual aversion disorder was similarly deleted from the DSM. The rationale behind this decision was that the diagnosis had very little empirical support. Furthermore, it was noted that sexual aversion shared a number of similarities with phobias and other anxiety disorders and therefore did not belong in the sexual dysfunctions chapter of the DSM-5 [21].
The new edition introduced duration and frequency requirements for sexual disorders. All diagnoses except substance- and medicationinduced sexual dysfunction now require a minimum duration of approximately 6 months as well as the presence of symptoms 75%-100% of the time. This development corrects what was seen as a flaw in sexual dysfunction diagnostic criteria, especially when compared to other DSM-IV diagnoses which did have duration requirements [1].
The changes introduced by the DSM-5 to the nosology of sexual dysfunctions aims at increasing its validity and clinical usefulness. Although some of the innovations were criticized by some members of the psychiatric community, it could be argued that, to a certain extent, the fifth edition was successful in reflecting the current state of research in the field sexual disorders.

Select your language of interest to view the total content in your interested language
Share This Article
Relevant Topics
Disc Abiraterone Acetate
Disc Abnormal Pap Test
Disc Abortion
Disc Abortion Pill
Disc Adenocarcinomas
Disc Adipose Derived Stem Cells (ASCs)
Disc Advanced HIV Infection Preventive Measures
Disc Advances in Breast Cancer Treatment
Disc Advances in HIV Diagnosis
Disc Advances in HIV Medications
Disc Advances in HIV Tests
Disc Advances in HIV Treatment
Disc Advances in In-vitro Fertilization
Disc Advances in Preventive Transmitted Disease
Disc Alternative Treatments for Breast Cancer
Disc Androgen Receptor
Disc Androgen deprivation therapy
Disc Antiretroviral Treatment
Disc Artificial Insemination
Disc Artificial Life
Disc Artificial Skin
Disc Artificial Taste and Smell
Disc Assisted Reproduction
Disc Automatic Technology
Disc Azoospermia
Disc Balantis
Disc Benign Prostate Hyperplasia
Disc Benign prostatic hyperplasia
Disc Bicalutamide
Disc Bioelectricity
Disc Bioengineering Biotechnology
Disc Biological Physics
Disc Biomarkers and Molecular Diagnosis of all Gynaecologic Cancers
Disc Biome Network
Disc Biomechatronics
Disc Biomedical-Engineering
Disc Birthcontrol
Disc Breast Cancer
Disc Breast Cancer Biology
Disc Breast Cancer Cure
Disc Breast Cancer Grading
Disc Breast Cancer Prevention
Disc Breast Cancer Radiotherapy
Disc Breast Cancer Research
Disc Breast Cancer Therapeutic & Market Analysis
Disc Breast Diseases
Disc Breast Screening
Disc Cabazitaxel
Disc Caesarean Section
Disc Cancer Stem Cells (CSCs)
Disc Cancer prevention
Disc Care to be Taken for New Borns
Disc Cervical Biopsy
Disc Cervical Cancer
Disc Cervical Cancer Prevention
Disc Cervical Cancer Treatment
Disc Cervical Dilation
Disc Cervical Erosin
Disc Cervical Intra-epithelial Neoplasia (CIN)
Disc Cervical Screening
Disc Cervix-Cancer
Disc Cesarean Delivery
Disc Clinical Gynecologic Oncology
Disc Colposcopy
Disc Cone Biopsy
Disc Congenital Heart Defects
Disc Congenital Nevi
Disc Corpus Luteum
Disc Correlative Embryology
Disc Cryptorchidism
Disc Cysts and Ovaries
Disc Degarelix
Disc Dental Stem Cells
Disc Diarrhea in Pregnancy
Disc Docetaxel
Disc Drug Resistance of HIV
Disc Electrostatics
Disc Embryology
Disc Embryonic Development
Disc Embryonic Stem Cells (ESCs)
Disc Endometreosis in Pregnancy
Disc Endometrial Cancer
Disc Endometriosis
Disc Endometriosis Treatment
Disc Enzalutamide
Disc Epidemiology of Gynecologic Cancers
Disc Epispadias
Disc Erectile Dysfunction
Disc External beam radiation
Disc Fallopian Tube
Disc Fallopian Tube Cancer
Disc Fallopian Tubes
Disc Fertility Acupuncture
Disc Fetal Stem Cell Therapy
Disc Fetus
Disc Fibrocystic Breast
Disc Frenulum Breve
Disc Gene Mapping
Disc General Care Taken for Mother and Child
Disc Genetic Code
Disc Genetic Disorder
Disc Genetic linkages
Disc Genital Warts
Disc Genitalia
Disc Genome Biology
Disc Genome Sequencing
Disc Genomics and Drug Development
Disc Germ cell tumours
Disc Gestational Trophoplastic Tumors
Disc Gonadotropin Releasing Hormone
Disc Goserelin acetate
Disc Gynecological Oncology
Disc Gynecology
Disc HIV Status
Disc HIV Super Infection
Disc HIV Vaccines
Disc HIV and Pregnancy
Disc HPV Vaccination
Disc Hematopoietic Stem Cells (HSCs)
Disc Hemolytic Disease of Newborn
Disc Hereditary Breast Cancer
Disc High Risk Pregnancy
Disc Highly Active Antiretroviral Therapy
Disc Hormonal Changes during Pregnancy
Disc Hormone therapy
Disc Human Fertilization and Embryogenesis
Disc Human Genetics
Disc Human Immunodeficiency Virus (HIV)
Disc Human Papillomavirus (HPV)
Disc Human Sperm
Disc Huntington disease
Disc Hydrocele
Disc Hypospadias
Disc Hysterectomy
Disc IUD
Disc IVF Treatment
Disc Impact Factor
Disc In Vitro Fertilization
Disc Infertility Treatment
Disc Inflammatory Breast Cancer
Disc Innovative HIV drugs
Disc Intalligent Materials
Disc Invasive Ductal Carcinoma
Disc Late Pregnancy Issues
Disc Leuprolide acetate
Disc Low Libido
Disc Lymph Node
Disc Making Strides in Breast Cancer
Disc Male Reproductive System
Disc Mammary Gland
Disc Mastectomy
Disc Maternal Psychology
Disc Maternal Depression
Disc Mendelian Genetics
Disc Menopause Symptoms
Disc Menstrualcycle
Disc Mesenchymal Stem Cells
Disc Metabolic Disorders
Disc Metabolic Engineering
Disc Metabolic Flux
Disc Metastatic Breast Cancer
Disc Morphogenesis
Disc Mother Health
Disc Motion Sickness Medicine
Disc Movement Disorder
Disc Multipotent Stem Cells
Disc Myeloid Stem Cells
Disc Nano material
Disc Nausea Pregnancy
Disc Neonatal Bowel Obstruction
Disc Neonatal Cholestasis
Disc Neonatal Conjunctivitis
Disc Neonatal Diabetes
Disc Neonatal Hepatitis
Disc Neonatal Jaundice
Disc Neonatal Lupus Erythematosus
Disc Neonatal Mortality
Disc Neonatal Nursing
Disc Neonatal Respiratory Distress Syndrome
Disc Neonatal Seizures
Disc Neonatal Stroke
Disc Neonatal Surgeries
Disc Neonatal Tetanus
Disc Neonatal Toxic Shock
Disc Neural Stem Cells (NSCs)
Disc Neuro Networks
Disc Neuroblastoma Cancer
Disc Newborn Illness
Disc Obstetrics
Disc Omentum Cancer
Disc Ovarian Cancer
Disc Ovarian Cancer Prognosis
Disc Ovarian Tumors
Disc Papanicolaou Screening
Disc Pathological aspects and molecular pathology of all Gynecologic Cancers
Disc Penile Fracture
Disc Penile cancer
Disc Pheromone
Disc Phimosis
Disc Physiological Changes during Pregnancy
Disc Plant Stem Cells
Disc Pluripotent Stem Cells
Disc Polycystic Ovary Syndrome
Disc Polycystic Ovary Syndrome (PCOS)
Disc Post Partum Haemorrhage
Disc Pre-implantation Genetic Diagnosis (PGD)
Disc Preclampsia in Pregnancy
Disc Pregnancy
Disc Pregnancy Care
Disc Pregnancy Constipation
Disc Pregnancy Diabetes
Disc Pregnancy Fitness
Disc Pregnancy Nutrition
Disc Premature Ovarian Failure (POF)
Disc Prenatal Care
Disc Prenatal Healthcare
Disc Preterm Birth
Disc Preterm Infant
Disc Priapism
Disc Primary Peritoneal Cancer
Disc Prostate Cancer
Disc Prostate-specific antigen
Disc Prosthetics
Disc Psychological Balance
Disc Quality of Life of Patients with Gynecologic Cancers
Disc Radical retropubic prostatectomy
Disc Radiotherapy for Breast Cancer
Disc Radium 223 Dichloride
Disc Reproductive Behavior
Disc Reproductive Cancer
Disc Reproductive Genetics
Disc Reproductive Health
Disc Reproductive Medicine
Disc Reproductive System
Disc Retrograde Ejaculation
Disc Risk Analysis: HIV
Disc Risk Behaviours of HIV/AIDS
Disc Robotic Science
Disc Semen Analysis
Disc Semen Analysis and Sperm Characteristics
Disc Sex Chromosomes
Disc Sex Hormones
Disc Sex Organ
Disc Sex-Determination
Disc Sexual Disorders
Disc Sexually Transmitted Disease
Disc Sexually Transmitted Disease (STD)
Disc Sexually Transmitted Diseases
Disc Smoking in Breast Cancer
Disc Smoking in Pregnancy
Disc Socio- Psychological Aspects of Gynecological Cancers
Disc Spermatocele
Disc Spermatogonia
Disc Spermatozoa
Disc Squamous Cell Cancer (SCC)
Disc Stem Cell
Disc Stem Cell Preservation
Disc Stem Cell Therapy for Diabetes
Disc Stem Cell Therapy for Osteoarthritis
Disc Stem Cell Transplant
Disc Stress in Pregnancy
Disc Targeted Molecular Therapy for all Gynaecologic Cancers
Disc Terminal Breast Cancer
Disc Termination of Pregnancy
Disc Testicular Cancer
Disc Testosterone
Disc Totipotent Stem Cells
Disc Transmission of Diseases from Mother to Child
Disc Tumor cell
Disc Tumor suppressor gene
Disc Ultrasound Pregnancy
Disc Umbilical Cord
Disc Unisexual Reproduction
Disc Uterine Cancer
Disc Uterus
Disc Vaccination in Neonates
Disc Vaginal Cancer
Disc Vaginal Oncology
Disc Varicocele
Disc Vasectomy
Disc Venereal Disease
Disc Vulva Cancer
Disc Woman Cancer
Disc Woman Diabetes
Disc Woman Disorders
Disc Woman Hormones
Disc Woman Mental Health
Disc Woman Psychology
Disc Womb Cancer
Disc Women's Fitness
Disc Women's Health
Recommended Journals
Disc Andrology & Gynecology
Disc Womens Health, Issues and Care
Disc Neonatal Biology
Disc Genital System & Disorders
Disc Contraceptive Studies
Disc Gynecologic Oncology
Disc Cervical Cancer
Disc Breast Cancer
Disc HIV & Retro Virus
Disc AIDS & Clinical Research
Disc Womens Health Care
Disc Human Genetics & Embryology
Disc Stem Cell Research & Therapy
Disc Biomedical Systems & Emerging Technologies
Disc Mother and Child Health
Disc Prostate Cancer
Disc Fertilization: In Vitro - IVF-Worldwide, Reproductive Medicine, Genetics & Stem Cell Biology
Disc Pregnancy and Child Health
Disc Gynecology & Obstetrics
Disc Andrology-Open Access
  View More»
Recommended Conferences
Disc 2nd Pregnancy and Child Health
Aug 29-31, 2016 ,Sao Paulo, Brazil
Disc Reproductive Health Summit
Aug 29- 31, 2016 Atlanta, USA
Disc 2nd World Congress on Polycystic Ovarian Syndrome
Oct 5-7, 2016, Orlando, USA
Disc 3rd Gynecology and Obstetrics
Oct 17-19, 2016, Dubai, UAE
View More»
Article Tools
Disc Export citation
Disc Share/Blog this article
Article usage
  Total views: 15414
  [From(publication date):
November-2013 - Jun 30, 2016]
  Breakdown by view type
  HTML page views : 11584
  PDF downloads :3830

Post your comment

captcha   Reload  Can't read the image? click here to refresh

OMICS International Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
OMICS International Conferences 2016-17
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri, Food, Aqua and Veterinary Science Journals

Dr. Krish

1-702-714-7001 Extn: 9040

Clinical and Biochemistry Journals

Datta A

1-702-714-7001Extn: 9037

Business & Management Journals


1-702-714-7001Extn: 9042

Chemical Engineering and Chemistry Journals

Gabriel Shaw

1-702-714-7001 Extn: 9040

Earth & Environmental Sciences

Katie Wilson

1-702-714-7001Extn: 9042

Engineering Journals

James Franklin

1-702-714-7001Extn: 9042

General Science and Health care Journals

Andrea Jason

1-702-714-7001Extn: 9043

Genetics and Molecular Biology Journals

Anna Melissa

1-702-714-7001 Extn: 9006

Immunology & Microbiology Journals

David Gorantl

1-702-714-7001Extn: 9014

Informatics Journals

Stephanie Skinner

1-702-714-7001Extn: 9039

Material Sciences Journals

Rachle Green

1-702-714-7001Extn: 9039

Mathematics and Physics Journals

Jim Willison

1-702-714-7001 Extn: 9042

Medical Journals

Nimmi Anna

1-702-714-7001 Extn: 9038

Neuroscience & Psychology Journals

Nathan T

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

John Behannon

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

1-702-714-7001 Extn: 9042

© 2008-2016 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version